Want to see HK:2393 full AI Analyst Report?
2393 Stock Chart & Stats
HK$0.06
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$0.06
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.04 - HK$0.17
Previous CloseN/A
Volume70.00K
Average Volume (3M)2.34M
Market Cap
HK$130.46M
Enterprise ValueHK$242.37
Total Cash (Recent Filing)HK$234.51M
Total Debt (Recent Filing)HK$211.05M
Price to Earnings (P/E)―
Beta0.54
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding2,331,590,000
10 Day Avg. Volume1,184,000
30 Day Avg. Volume2,342,546
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)0.56
Price to Sales (P/S)0.14
P/FCF Ratio0.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Balance SheetThe return to positive equity and materially lower leverage reduce balance-sheet strain and improve financial flexibility. This gives Yestar a stronger foundation to fund operations and absorb business volatility than it had during the negative-equity period.
Strong 2025 Cash GenerationStrong operating and free cash flow despite reported net losses indicates meaningful cash conversion in the latest year. If sustained, this can support working capital, debt management and investment without relying as heavily on external financing.
Healthcare Segment DiversificationExposure to both medical aesthetics and ophthalmic care provides a broader healthcare-services platform than reliance on one treatment category. This diversification may help spread demand risk across distinct customer needs and service markets over time.
Bears Say
Sharp Revenue ContractionThe pronounced top-line decline signals weakened demand, volumes or business activity and reduces operating leverage. Persistent revenue pressure would constrain the company’s ability to cover fixed costs, reinvest in services and rebuild sustainable profitability.
Unstable ProfitabilityA return to losses and wide swings in reported margins make earnings quality difficult to assess. Without stable profitability, internally generated capital may remain unreliable and the company could have less capacity to fund growth or withstand weaker operating conditions.
Volatile Cash-Flow DurabilityAlthough cash generation rebounded strongly in 2025, the prior negative and weak periods show that cash conversion has not been dependable across the cycle. This volatility raises the risk that future downturns could again pressure liquidity and investment capacity.
Yestar Healthcare Holdings Co Ltd News
2393 FAQ
What was Yestar Healthcare Holdings Co Ltd’s price range in the past 12 months?
Yestar Healthcare Holdings Co Ltd lowest stock price was HK$0.04 and its highest was HK$0.17 in the past 12 months.
What is Yestar Healthcare Holdings Co Ltd’s market cap?
Yestar Healthcare Holdings Co Ltd’s market cap is HK$130.46M.
When is Yestar Healthcare Holdings Co Ltd’s upcoming earnings report date?
Yestar Healthcare Holdings Co Ltd’s upcoming earnings report date is Aug 28, 2026 which is in 3 days.
How were Yestar Healthcare Holdings Co Ltd’s earnings last quarter?
Yestar Healthcare Holdings Co Ltd released its earnings results on Mar 27, 2026. The company reported -HK$0.038 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Yestar Healthcare Holdings Co Ltd overvalued?
According to Wall Street analysts Yestar Healthcare Holdings Co Ltd’s price is currently Overvalued.
Does Yestar Healthcare Holdings Co Ltd pay dividends?
Yestar Healthcare Holdings Co Ltd pays a Annually dividend of HK$0.055 which represents an annual dividend yield of N/A. See more information on Yestar Healthcare Holdings Co Ltd dividends here
What is Yestar Healthcare Holdings Co Ltd’s EPS estimate?
Yestar Healthcare Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yestar Healthcare Holdings Co Ltd have?
Yestar Healthcare Holdings Co Ltd has 2,331,590,000 shares outstanding.
What happened to Yestar Healthcare Holdings Co Ltd’s price movement after its last earnings report?
Yestar Healthcare Holdings Co Ltd reported an EPS of -HK$0.038 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.02%.
Which hedge fund is a major shareholder of Yestar Healthcare Holdings Co Ltd?
Currently, no hedge funds are holding shares in HK:2393
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yestar Healthcare Holdings Co Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.31%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-12.60%
Trailing 12-Months
Company Description
Yestar Healthcare Holdings Co Ltd
Yestar Healthcare Holdings Company Limited, an investment holding company, manufactures, distributes, and sells medical imaging products in Mainland China. The company operates in two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells color photographic paper and industrial NDT x-ray films and PWB films, as well as trades in imaging equipment. The Medical Products and Equipment segment manufactures and sells medical dry, medical wet, and dental films, as well as sells medical equipment and diagnostic reagents. The company also engages in the management of supply chain and service of freight transportation equipment, as well as development of biotechnology. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People’s Republic of China.
Technical Analysis
Peijia Medical Ltd.
―
Acotec Scientific Holdings Limited
―
Vincent Medical Holdings Limited
―
Sisram Medical Ltd.
―
Venus Medtech (Hangzhou), Inc. Class H
―